연구동향 분석

Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification

Enkhee Ochirjav Bayarmaa Enkhbat Tuul Baldandorj 최기영 2019년

논문상세정보
인용/피인용
' Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Chromosome deletion
  • Glioma
  • classification
  • isocitratedehydrogenase
  • world health organization
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
955 0

0.0%

' Reclassification of Mongolian Diffuse Gliomas According to the Revised 2016 World Health Organization Central Nervous System Tumor Classification' 의 참고문헌

  • cIMPACT-NOW : a practical summary of diagnostic points from Round 1 updates
    Louis DN [2019]
  • WHO 2016 classification of gliomas
    Wesseling P [2018]
  • Type and frequency of IDH1and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age : a study of 1, 010 diffuse gliomas
    Hartmann C [2009]
  • The updated World Health Organization glioma classification : cellular and molecular origins of adult infiltrating gliomas
    Pisapia DJ [2017]
  • The next generation of glioma biomarkers : MGMT methylation, BRAF fusions and IDH1 mutations
  • The 2016 World Health Organization classification of tumors of the central nervous system : a summary
    Louis DN [2016]
  • The 2007 WHO classification of tumours of the central nervous system
    Louis DN [2007]
  • Subgrouping of gliomas on the basis of genetic profiles
    Hirose Y [2013]
  • Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification
    Akagi Y [2018]
  • Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort
    Tabouret E [2016]
  • Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
    Bigner SH [1999]
  • Molecular characteristics of glioblastoma with 1p/19q co-deletion
    Mizoguchi M [2012]
  • Loss of heterozygosity of TRIM3 in malignant gliomas
    Boulay JL [2009]
  • Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas
    Sanson M [2009]
  • International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
  • IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
    Ichimura K [2009]
  • IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors
    Mellai M [2011]
  • IDH1 and IDH2 mutations in gliomas
    Cohen AL [2013]
  • IDH1 and IDH2 mutations in gliomas
    Yan H [2009]
  • Comprehensive, integrative genomic analysis of diffuse lowergrade gliomas
  • Clinical significance of the 2016WHO classification in Japanese patients with gliomas
    Iuchi T [2018]
  • Analysis of the IDH1 codon 132 mutation in brain tumors
    Balss J [2008]
  • Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis
    Hata N [2006]
  • Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities
    Reuss DE [2015]
  • A simplified overview of World Health Organization classification update of central nervous system tumors 2016
    Gupta A [2017]